Frequentist ranking in network meta-analysis
This method ranks treatments in network meta-analyses using a frequentist approach, without needing complex resampling. It calculates a score called the P-score that shows how certain we can be that one treatment is better than others, based on standard statistical results from the analysis.
At a glance
Use when
You need a simple, interpretable ranking of treatments in a frequentist network meta-analysis and want to avoid resampling or Bayesian modeling.
Avoid when
You require full probabilistic inference or uncertainty quantification about ranks, or when normality assumptions are severely violated.
Inputs
Point estimates and standard errors from a frequentist network meta-analysis model (assuming normality).
Outputs
P-scores for each treatment, indicating the mean certainty of being superior to other treatments, and resulting treatment rankings.
How it works
The method introduces the P-score, a frequentist analogue to the Bayesian SUCRA, for ranking treatments in network meta-analysis. P-scores are computed as the mean of one-sided p-values derived from the point estimates and standard errors under a normality assumption. They represent the average certainty that a treatment is superior to competing treatments and induce a rank order that accounts for both effect size and precision, without requiring resampling or Bayesian posterior simulation.
- HTA domains
- Clinical Effectiveness
- Categories
- Indirect Comparisons
- Assumptions
- The sampling distribution of treatment effects is approximately normal; ranking should reflect both effect size and precision; a higher point estimate (or more favorable direction) indicates better performance.
- Strengths
- Does not require resampling or Bayesian simulation, making it computationally simple.,P-scores are nearly identical to SUCRA values, enabling comparable interpretation.,Incorporates both effect size and precision in ranking.
- Limitations
- Offers little advantage over direct inspection of confidence intervals.,Relies on normality assumptions for effect estimates.,Does not provide probabilistic statements in the same way as Bayesian methods.
- Also known as
- P-score, Frequentist SUCRA
Questions this answers
- › Which treatment is most likely to be the best in a network of interventions?
- › How certain can we be about the relative ranking of each treatment?
- › How can treatment rankings be derived in frequentist network meta-analysis without resampling?
- › How does precision of estimates influence the rank order of treatments?
- › Can Bayesian-style ranking metrics be replicated in a frequentist framework?
- › What is a simple way to summarize treatment hierarchy in network meta-analysis?
References & sources
Related methods
Similar by meaning
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.